T1	intervention 60 85	Bone Pain Education Video
T2	condition 98 107	Bone Pain
T4	location 526 539	United States
T5	total-participants 541 554	Three hundred
T3	age 561 570	≥18 years
T6	eligibility 578 741	with newly diagnosed stage I -III breast cancer, who were planning ≥4 cycles of neoadjuvant or adjuvant chemotherapy with pegfilgrastim support starting in cycle 1
T10	outcome 1216 1250	Patient-reported maximum bone pain
T11	outcome 1383 1404	measures of bone pain
T7	control 782 803	general education DVD
T8	cv-cont-mean 1309 1312	3.2
T9	iv-cont-mean 1317 1320	3.5
T12	outcome 1443 1452	Bone pain
T13	outcome 1537 1561	Bone pain medication use
